"Also, does anyone know whether CDY are receiving any royalties (or even signing any agreements) in relation to the dozens of other patents they have on their balance sheet?"
Denti you have raised a couple of issues which I have had a quick look at. I am not the sharpest tool in the pack so someone better qualified may correct me but there does not appear to be too many current Australian patents. Link to the Patents Office info hereunder -
http://pericles.ipaustralia.gov.au/ols/auspat/quickSearch.do?queryString=cellmid&resultsPerPage=
In relation to royalties I have attempted to identify from the 2019 Annual Report just what has been received. From Note 2 we have total Revenue and other income for Lyramid as $1,008,217 which includes Diagnostic Income of $105,582. Note 3 discloses Royalties and Licence Fees of $87,787 and Government Grants of $807,973 which I assume is included in the Lyramid revenue.
All very interesting but does not answer your question of whether we have agreements other than with PEB.
- Forums
- ASX - By Stock
- AN1
- PacificEdge update
PacificEdge update, page-204
-
- There are more pages in this discussion • 73 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add AN1 (ASX) to my watchlist
|
|||||
Last
0.8¢ |
Change
0.000(0.00%) |
Mkt cap ! $3.690M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Featured News
AN1 (ASX) Chart |
Day chart unavailable